Impact of air pollution on lung inflammation and the role of toll-like receptors

International Journal of Interferon, Cytokine and Mediator Research

Volumn 4, Issue 1, 2012, Pages 43-57

  Plummer, Laurel E ^a   Smiley Jewell, Suzette ^a   Pinkerton, Kent E ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Air pollution; Inflammation; Lung; Ozone; Particulate matter; TLR; Toll like receptor

Indexed keywords

OZONE; TOLL LIKE RECEPTOR;

AIR POLLUTANT; AIR POLLUTION; AMBIENT AIR; ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CYSTIC FIBROSIS; DISEASE ASSOCIATION; DISEASE EXACERBATION; DISEASE PREDISPOSITION; ENVIRONMENTAL EXPOSURE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; HUMAN IMPACT (ENVIRONMENT); IMMUNE RESPONSE; IMMUNOMODULATION; OUTCOME ASSESSMENT; OXIDATIVE STRESS; PARTICULATE MATTER; PATHOGENESIS; PNEUMONIA; PROTEIN FUNCTION; PROTEIN STRUCTURE; REVIEW; RISK ASSESSMENT; RISK FACTOR; SIGNAL TRANSDUCTION; UPREGULATION;

EID: 84864083955     PISSN: None     EISSN: 1179139X     Source Type: Journal    
DOI: None     Document Type: Review

References (121)

1. Becker S, Dailey LA, Soukup JM, Grambow SC, Devlin RB, Huang YC. Seasonal variations in air pollution particle-induced inflammatory mediator release and oxidative stress. Environ Health Perspect. 2005;113(8):1032-1033.
2. Bell ML, Ebisu K, Peng RD, et al. Seasonal and regional short-term effects of fine particles on hospital admissions in 202 US counties,1999-2005. Am J Epidemiol. 2008;168(11):1301-1310.
3. Farina F, Sancini G, Mantecca P, Gallinotti D, Camatini M, Palestini P. The acute toxic effects of particulate matter in mouse lung are related to size and season of collection. Toxicol Lett. 2011;202(3):209-217.
4. Hetland RB, Cassee FR, Lag M, Refsnes M, Dybing E, Schwarze PE. Cytokine release from alveolar macrophages exposed to ambient particulate matter: heterogeneity in relation to size, city and season. Part Fibre Toxicol. 2005;2:4.
5. Tsan M-F, Gao B. Endogenous ligands of Toll-like receptors. J Leukoc Biol. 2004;76:514-519.
6. Bauer RN, Diaz-Sanchez D, Jaspers I. Effects of air pollutants on innate immunity: the role of Toll-like receptors and nucleotide-binding oligomerization domain-like receptors. J Allergy Clin Immunol. 2012;129(1):14-26.
7. Menache MG, Miller FJ, Raabe OG. Particle inhalability curves for humans and small laboratory animals. Ann Occup Hyg. 1995;39(3): 317-328.
8. Mendez LB, Gookin G, Phalen RF. Inhaled aerosol particle dosimetry in mice: a review. Inhal Toxicol. 2010;22(12):1032-1037.
9. Stuart BO. Deposition and clearance of inhaled particles. Environ Health Perspect. 1984;55:369-390.
10. Rylander R. Endotoxin and occupational airway disease. Curr Opin Allergy Clin Immunol. 2006;6(1):62-66.
11. Alexis NE, Lay JC, Zeman K, et al. Biological material on inhaled coarse fraction particulate matter activates airway phagocytes in vivo in healthy volunteers. J Allergy Clin Immunol. 2006;117(6): 1396-1403.
12. Wilson WE, Suh HH. Fine particles and coarse particles: concentration relationships relevant to epidemiologic studies. J Air Waste Manag Assoc. 1997;47(12):1238-1249.
13. Chow J, Watson J, Lowenthal D, et al. PM(10) and PM(2.5) Compositions in California San Joaquin Valley. Aerosol Sci Technol. 1993;18(2):105-128.
14. Chow JC. Health effects of fine particulate air pollution: lines that connect. J Air Waste Manag Assoc. 2006;56(6):707-708.
15. Vidrio E, Jung H, Anastasio C. Generation of hydroxyl radicals from dissolved transition metals in surrogate lung fluid solutions. Atmos Environ. 2008;42(18):4369-4379.
16. Gurgueira SA, Lawrence J, Coull B, Murthy GGK, Gonzlez-Flecha B. Rapid increases in the steady-state concentration of reactive oxygen species in the lungs and heart after particulate air pollution inhalation. Environ Health Perspect. 2002;110(8):749-755.
17. Huang Y-CT, Li Z, Carter JD, Soukup JM, Schwartz DA, Yang IV. Fine ambient particles induce oxidative stress and metal binding genes in human alveolar macrophages. Am J Respir Cell Mol Biol. 2009;41(5):544-552.
18. Imrich A, Ning YY, Lawrence J, et al. Alveolar macrophage cytokine response to air pollution particles: oxidant mechanisms. Toxicol Appl Pharmacol. 2007;218(3):256-264.
19. Li N, Sioutas C, Cho A, et al. Ultrafine particulate pollutants induce oxidative stress and mitochondrial damage. Environ Health Perspect. 2003;111(4):455-460.
20. Kelly FJ, Fussell JC. Air pollution and airway disease. Clin Exp Allergy. 2011;41(8):1059-1071.
21. Laden F, Neas LM, Dockery DW, Schwartz J. Association of fine particulate matter from different sources with daily mortality in six US cities. Environ Health Perspect. 2000;108(10):941-947.
22. Krewski D, Burnett R, Jerrett M, et al. Mortality and long-term exposure to ambient air pollution: ongoing analyses based on the American Cancer Society cohort. J Toxicol Environ Health Part A. 2005;68(13-14):1093-1109.
23. Pope CA 3rd, Thun MJ, Namboodiri MM, et al. Particulate air pollution as a predictor of mortality in a prospective study of US adults. Am J Respir Crit Care Med. 1995;151(3 Pt 1):669-674.
24. Schwartz J. Short-term fluctuations in air pollution and hospital admissions of the elderly for respiratory disease. Thorax. 1995;50(5): 531-538.
25. Bosson J, Stenfors N, Bucht A, et al. Ozone-induced bronchial epithelial cytokine expression differs between healthy and asthmatic subjects. Clin Expl Allergy. 2003;33(6):777-782.
26. Al-Hegelan M, Tighe RM, Castillo C, Hollingsworth JW. Ambient ozone and pulmonary innate immunity. Immunol Res. 2011;49(1-3): 173-191.
27. Samet JM, Graff D, Berntsen J, Ghio AJ, Huang Y-CT, Devlin RB. A comparison of studies on the effects of controlled exposure to fine, coarse and ultrafine ambient particulate matter from a single location. Inhal Toxicol. 2007;19 Suppl 1:29-32.
28. Ghio AJ, Kim C, Devlin RB. Concentrated ambient air particles induce mild pulmonary inflammation in healthy human volunteers. Am J Respir Crit Care Med. 2000;162(3 Pt 1):981-988.
29. Behndig AF, Mudway IS, Brown JL, et al. Airway antioxidant and inflammatory responses to diesel exhaust exposure in healthy humans. Eur Respir J. 2006;27(2):359-365.
30. Allen RW, Mar T, Koenig J, et al. Changes in lung function and airway inflammation among asthmatic children residing in a woodsmoke-impacted urban area. Inhal Toxicol. 2008; 20(4):423-433.
31. McCreanor J, Cullinan P, Nieuwenhuijsen MJ, et al. Respiratory effects of exposure to diesel traffic in persons with asthma. N Engl J Med. 2007;357:2348-2358.
32. Alexis NE, Lay JC, Hazucha M, et al. Low-level ozone exposure induces airways inflammation and modifies cell surface phenotypes in healthy humans. Inhal Toxicol. 2010;22(7):593-600.
33. Kim CS, Alexis NE, Rappold AG, et al. Lung function and inflammatory responses in healthy young adults exposed to 0.06 ppm ozone for 6.6 hours. Am J Respir Crit Care Med. 2011;183(9):1215-1221.
34. Khatri SB, Holguin FC, Ryan PB, Mannino D, Erzurum SC, Teague WG. Association of ambient ozone exposure with airway inflammation and allergy in adults with asthma. J Asthma. 2009;46(8):777-785.
35. Scannell C, Chen L, Aris RM, et al. Greater ozone-induced inflammatory responses in subjects with asthma. Am J Respir Crit Care Med. 1996; 154(1):24-29.
36. Peters JM, Avol E, Gauderman WJ, et al. A study of twelve southern California communities with differing levels and types of air pollution - II. Effects on pulmonary function. Am J Respir Crit Care Med. 1999; 159(3):768-775.
37. Clark NA, Demers PA, Karr CJ, et al. Effect of early life exposure to air pollution on development of childhood asthma. Environ Health Perspect. 2010;118(2):284-290.
38. Pinkerton KE, Joad JP. Influence of air pollution on respiratory health during perinatal development. Clin Exp Pharmacol Physiol. 2006; 33(3):269-272.
39. Sharkhuu T, Doerfler DL, Krantz QT, Luebke RW, Linak WP, Gilmour MI. Effects of prenatal diesel exhaust inhalation on pulmonary inflammation and development of specific immune responses. Toxicol Lett. 2010; 196(1):12-20.
40. Sharkhuu T, Doerfler DL, Copeland C, Luebke RW, Gilmour MI. Effect of maternal exposure to ozone on reproductive outcome and immune, inflammatory, and allergic responses in the offspring. J Immunotoxicol. 2011;8(2):183-194.
41. Vedal S, Petkau J, White R, Blair J. Acute effects of ambient inhalable particles in asthmatic and nonasthmatic children. Am J Respir Crit Care Med. 1998;157(4):1034-1043.
42. Chalupa DC, Morrow PE, Oberdorster G, Utell MJ, Frampton MW. Ultrafine particle deposition in subjects with asthma. Environ Health Perspect. 2004;112(8):879-882.
43. Davies DE, Wicks J, Powell RM, Puddicombe SM, Holgate ST. Airway remodeling in asthma: new insights. J Allergy Clin Immunol. 2003; 111(2):215-225.
44. Baines KJ, Simpson JL, Gibson PG. Innate immune responses are increased in chronic obstructive pulmonary disease. PLoS One. 2011; 6(3):e18426.
45. Sunyer J. Urban air pollution and chronic obstructive pulmonary disease: a review. Eur Resp J. 2001;17(5):1024-1033.
46. Zanobetti A, Schwartz J, Gold D. Are there sensitive subgroups for the effects of airborne particles? Environ Health Perspect. 2000;108(9): 841-845.
47. Peacock JL, Anderson HR, Bremner SA, et al. Outdoor air pollution and respiratory health in patients with COPD. Thorax. 2011;66(7):591-596.
48. Arbex MA, de Souza Conceicao GM, Cendon SP, et al. Urban air pollution and chronic obstructive pulmonary disease-related emergency department visits. J Epidemiol Community Health. 2009;63(10):777-783.
49. Sigaud S, Goldsmith CA, Zhou H, et al. Air pollution particles diminish bacterial clearance in the primed lungs of mice. Toxicol Appl Pharmacol. 2007;223(1):1-9.
50. Zhou HW, Kobzik L. Effect of concentrated ambient particles on macrophage phagocytosis and killing of Streptococcus pneumoniae. Am J Respir Cell Mol Biol. 2007;36(4):460-465.
51. Chauhan AJ, Johnston SL. Air pollution and infection in respiratory illness. Br Med Bull. 2003;68:95-112.
52. MA. Innate immunity and airway inflammation. J Innate Immun. 2010;2(2):95.
53. Koren HS, Devlin RB, Graham DE, et al. Ozone-induced inflammation in the lower airways of human subjects. Am Rev Respir Dis. 1989; 139(2):407-415.
54. Karin M, Lawrence T, Nizet V. Innate immunity gone awry: linking microbial infections to chronic inflammation and cancer. Cell. 2006; 124(4):823-835.
55. Christman JW, Sadikot RT, Blackwell TS. The role of nuclear factor-kappa B in pulmonary diseases. Chest. 2000;117(5):1482-1487.
56. Calixto JB, Campos MM, Otuki MF, Santos ARS. Anti-inflammatory compounds of plant origin. Part II. Modulation of pro-inflammatory cytokines, chemokines and adhesion molecules. Planta Med. 2004; 70(2):93-103.
57. Haddad JJ. Cytokines and related receptor-mediated signaling pathways. Biochem Biophys Res Commun. 2002;297(4):700-713.
58. Frush S, Li Z, Potts EN, et al. The role of the extracellular matrix protein mindin in airway response to environmental airways injury. Environ Health Perspect. 2011;119(10):1403-1408.
59. Garantziotis S, Li Z, Potts EN, et al. TLR4 is necessary for hyaluronan-mediated airway hyperresponsiveness after ozone inhalation. Am J Respir Crit Care Med. 2010;181(7):666-675.
60. Moldoveanu B, Otmishi P, Jani P, et al. Inflammatory mechanisms in the lung. J Inflamm Res. 2009;(2):1-11.
61. Li Z, Potts-Kant EN, Garantziotis S, Foster WM, Hollingsworth JW. Hyaluronan signaling during ozone-induced lung injury requires TLR4, MyD88, and TIRAP. Plos One. 2011;6(11):e27137.
62. Kleeberger SR. Genetic aspects of susceptibility to air pollution. Eur Resp J. 2003;21(Suppl 40):52s-56s.
63. Romieu I, Moreno-Macias H, London SJ. Gene by environment interaction and ambient air pollution. Proc Am Thorac Soc. 2010;7: 116-122.
64. Yang IA, Fong KM, Zimmerman PV, Holgate ST, Holloway JW. Genetic susceptibility to the respiratory effects of air pollution. Thorax. 2008;63(6):555-563.
65. Halonen JI, Lanki T, Tiittanen P, Niemi JV, Loh M, Pekkanen J. Ozone and cause-specific cardiorespiratory morbidity and mortality. J Epidemiol Community Health. 2010;64(9):814-820.
66. Hertz-Picciotto I, Baker RJ, Yap PS, et al. Early childhood lower respiratory illness and air pollution. Environ Health Perspect. 2007; 115(10):1510-1518.
67. Joad JP, Ji CM, Kott KS, Bric JM, Pinkerton KE. In-utero and postnatal effects of sidestream cigaretter-smoke exposure on lung function, hyperresponsiveness and neuroendocrine cells in rats. Toxicol Appl Pharmacol. 1995;132(1):63-71.
68. Bateson TF, Schwartz J. Children's response to air pollutants. J Toxicol Environ Health A. 2008;71(3):238-243.
69. Namdeo A, Tiwary A, Farrow E. Estimation of age-related vulnerability to air pollution: assessment of respiratory health at local scale. Environ Int. 2011;37(5):829-837.
70. Ji M, Cohan DS, Bell ML. A meta-analysis of association between short-term ambient ozone exposure and respiratory hospital admissions. Epidemiology. 2011;22(1):S203.
71. Morello-Frosch R, Pastor M, Sadd J. Environmental justice and Southern California's "riskscape" - the distribution of air toxics exposures and health risks among diverse communities. Urban Aff Rev Thousand Oaks Calif. 2001;36(4):551-578.
72. Morello-Frosch R, Pastor M, Porras C, Sadd J. Environmental justice and regional inequality in southern California: implications for future research. Environ Health Perspec. 2002;110:149-154.
73. Sadd JL, Pastor M, Morello-Frosch R, Scoggins J, Jesdale B. Playing it safe: assessing cumulative impact and social vulnerability through an environmental justice screening method in the South Coast Air Basin, California. Int J Environ Res Public Health. 2011;8(5):1441-1459.
74. Miranda ML, Edwards SE, Keating MH, Paul CJ. Making the environmental justice grade: the relative burden of air pollution exposure in the United States. Int J Environ Res Public Health. 2011; 8(6):1755-1771.
75. Cakmak S, Dales RE, Rubio MA, Vidal CB. The risk of dying on days of higher air pollution among the socially disadvantaged elderly. Environ Res. 2011;111(3):388-393.
76. Basu S, Fenton MJ. Toll-like receptors: function and roles in lung disease. Am J Physiol Lung Cell Mol Physiol. 2004;286(5): L887-L892.
77. Schwartz DA, Cook DN. Polymorphisms of the toll-like receptors and human disease. Clin Infect Dis. 2005;41:S403-S407.
78. Lafferty EI, Qureshi ST, Schnare M. The role of toll-like receptors in acute and chronic lung inflammation. J Inflamm (Lond). 2010;7:57.
79. Jeong E, Lee JY. Intrinsic and extrinsic regulation of innate immune receptors. Yonsei Med J. 2011;52(3):379-392.
80. Armant MA, Fenton MJ. Toll-like receptors: a family of pattern recognition receptors in mammals. Genome Biol. 2002;3: reviews3011.1-reviews3011.6.
81. Chen K, Xiang Y, Yao X, et al. The active contribution of Toll-like receptors to allergic airway inflammation. Int Immunopharmacol. 2011;11(10):1391-1398.
82. Beg AA. Endogenous ligands of Toll-like receptors: implications for regulating inflammatory and immune responses. Trends Immunol. 2002;23(11):509-512.
83. Aderem A, Ulevitch RJ. Toll-like receptors in the induction of the innate immune response. Nature. 2000;406(6797):782-787.
84. Akira S, Takeda K. Toll-like receptor signalling. Nat Rev Immunol. 2004;4(7):499-511.
85. Kovach MA, Standiford TJ. Toll like receptors in diseases of the lung. Int Immunopharmaco. 2011;11(10):1399-1406.
86. Chaudhuri N, Dower SK, Whyte MKB, Sabroe I. Toll-like receptors and chronic lung disease. Clin Sci. 2005;109:125-133.
87. Bauer AK, Rondini EA, Hummel KA, et al. Identification of candidate genes downstream of TLR4 signaling after ozone exposure in mice: a role for heat-shock protein 70. Environ Health Perspect. 2011;119(8): 1091-1097.
88. Menetrez MY, Foarde KK, Esch RK, et al. An evaluation of indoor and outdoor biological particulate matter. Atmos Environ. 2009;43(34): 5476-5483.
89. Ning Y, Imrich A, Goldsmith C-A, Qin G, Kobzik L. Alveolar macrophage cytokine production in response to air particles in vitro: role of endotoxin. J Toxicol Environ Health A. 2000;59(3):165-180.
90. Rylander R. Endotoxin in the environment - exposure and effects. J Endotoxin Res. 2002;8(4):241-252.
91. Wegesser TC, Last JA. Mouse lung inflammation after instillation of particulate matter collected from a working dairy barn. Toxicol Appl Pharmacol. 2009;236(3):348-357.
92. Timm M, Madsen AM, Hansen JV, Moesby L, Hansen EW. Assessment of the total inflammatory potential of bioaerosols by using a granulocyte assay. Appl Environ Microbiol. 2009;75(24):7655-7662.
93. Becker S, Fenton MJ, Soukup JM. Involvement of microbial components and Toll-like receptors 2 and 4 in cytokine responses to air pollution particles. Am J Respir Cell Mol Biol. 2002;27(5): 611-618.
94. Williams AS, Leung SY, Nath P, et al. Role of TLR2, TLR4, and MyD88 in murine ozone-induced airway hyperresponsiveness and neutrophilia. J Appl Physiol. 2007;103(4):1189-1195.
95. Jiang DH, Liang JR, Fan J, et al. Regulation of lung injury and repair by Toll-like receptors and hyaluronan. Nat Med. 2005;11(11): 1173-1179.
96. Willart MAM, Lambrecht BN. The danger within: endogenous danger signals, atopy and asthma. Clin Exp Allergy. 2009;39(1):12-19.
97. Kosmider B, Loader JE, Murphy RC, Mason RJ. Apoptosis induced by ozone and oxysterols in human alveolar epithelial cells. Free Radic Biol Med. 2010;48(11):1513-1524.
98. Ramage L. Expression or C-reactive protein and heat-shock protein-70 in the lung epithelial cell line A549, in response to PM10 Exposure. Inhal Toxicol. 2004;16:447-452.
99. Erridge C. Endogenous ligands of TLR2 and TLR4: agonists or assistants? J Leukoc Biol. 2010;87(6):989-999.
100. Hollingsworth JW, Cook DN, Brass DM, et al. The role of toll-like receptor 4 in environmental airway injury in mice. Am J Respir Crit Care Med. 2004;170(2):126-132.
101. Hollingsworth JW, Cook DN, Schwartz DA. Toll-like receptors and airway disease. In: O'Neill LA, Brint E, editors. Toll-like Receptors in Inflammation. Basel: Birkhäuser; 2006.
102. Kleeberger SR, Reddy SP, Zhang L-Y, Cho H-Y, Jedlicka AE. Toll-like receptor 4 mediates ozone-induced murine lung hyperpermeability via inducible nitric oxide synthase. Am J Physiol Lung Cell Mol Physiol. 2001;280:326-333.
103. Williams MA, Porter M, Horton M, et al. Ambient particulate matter directs nonclassic dendritic cell activation and a mixed TH1/TH2-like cytokine response by naive CD4+ T cells. J Allergy Clin Immunol. 2007;119:488-497.
104. Inoue K, Takano H, Yanagisawa R, et al. The role of Toll-like receptor 4 in airway inflammation induced by diesel exhaust particles. Arch Toxicol. 2006;80(5):275-279.
105. Brook RD, Rajagopalan S, Pope CA, et al. Particulate matter air pollution and cardiovascular disease an update to the scientific statement from the American Heart Association. Circulation. 2010; 121(21):2331-2378.
106. Barraza-Villarreal A, Sunyer J, Hernandez-Cadena L, et al. Air pollution, airway inflammation, and lung function in a cohort study of Mexico City schoolchildren. Environ Health Perspect. 2008; 116(6):832-838.
107. Tesse R, Pandey RC, Kabesch M. Genetic variations in toll-like receptor pathway genes influence asthma and atopy. Allergy. 2011;66(3):307-316.
108. Droemann D, Goldmann T, Tiedje T, Zabel P, Dalhoff K, Schaaf B. Toll-like receptor 2 expression is decreased on alveolar macrophages in cigarette smokers and COPD patients. Respir Res. 2005;6:68.
109. von Scheele I, Larsson K, Dahlen B, et al. Toll-like receptor expression in smokers with and without COPD. Respir Med. 2011; 105(8):1222-1230.
110. Cook DN, Pisetsky DS, Schwartz DA. Toll-like receptors in the pathogenesis of human disease. Nat Immunol. 2004;5(10):975-979.
111. Zaborowski T, Wojas-Krawczyk K, Krawczyk P, et al. The effect of CD14 and TLR4 gene polymorphisms on the occurrence of atopic and non-atopic asthma. Adv Clin Exp Med. 2011;20(4):413-421.
112. Kormann MSD, Depner M, Harti D, et al. Toll-like receptor heterodimer variants protect from childhood asthma. J Allergy Clin Immunol. 2008;122(1):86-92.
113. Bottema RWB, Kerkhof M, Reijmerink NE, et al. Gene-gene interaction in regulatory T-cell function in atopy and asthma development in childhood. J Allergy Clin Immunol. 2010;126(2):338-346.
114. Kerkhof M, Postma DS, Brunekreef B, et al. Toll-like receptor 2 and 4 genes influence susceptibility to adverse effects of traffic-related air pollution on childhood asthma. Thorax. 2010;65(8):690-697.
115. Qian X-b, Wu Y, Cao S-y, et al. Association of single nucleotide polymorphisms in the promoter region of the TLR9 gene with childhood atopic asthma. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2011;28(2):185-189.
116. Lange NE, Zhou X, Lasky-Su J, et al. Comprehensive genetic assessment of a functional TLR9 promoter polymorphism: no replicable association with asthma or asthma-related phenotypes. BMC Med Genet. 2011;12:26.
117. Xirakia C, Koltsida O, Stavropoulos A, et al. Toll-like receptor 7-triggered immune response in the lung mediates acute and long-lasting suppression of experimental asthma. Am J Respir Crit Care Med. 2010;181(11):1207-1216.
118. Kim KW, Lee KE, Hong JY, et al. Involvement of IL-10 gene promoter polymorphisms in the susceptibility for childhood asthma. Lung. 2011;189(5):417-423.
119. Reijmerink NE, Bottema RWB, Kerkhof M, et al. TLR-related pathway analysis: novel gene-gene interactions in the development of asthma and atopy. Allergy. 2010;65(2):199-207.
120. Yang IV, Jiang WW, Rutledge HR, et al. Identification of novel innate immune genes by transcriptional profiling of macrophages stimulated with TLR ligands. Mol Immunol. 2011;48(15-16):1886-1895.
121. Salam MT, Byun HM, Lurmann F, et al. Genetic and epigenetic variations in inducible nitric oxide synthase promoter, particulate pollution, and exhaled nitric oxide levels in children. J Allergy Clin Immunol. 2012;129(1):232-239.